Inspiring A New Era Of Patient-Centric Medicines

Pharmaceutical patients are taking an increasingly active role in their own health and becoming more empowered as a result. This shift is driving a new wave of patient-centric medicines which promote better adherence, improve medical benefits, and bolster market perception of the drug product. Innovative technologies such as nanoparticle engineering and artificial intelligence (AI) powered in silico experiments are aiding the transition, placing patient-centricity at the forefront when designing, developing and manufacturing drugs.

These advances are enabling the production of more eco-friendly drugs that are effective at lower doses with reduced side effects. While elements such as an environmentally conscious manufacturing process may not seem inherently patient-centric, the recent rise in transparency and increased access to information for pharma companies places issues such as sustainability as top-of-mind for consumers. Novel drug delivery applications also play a key role in the shift toward personalized medicine. The increased bioavailability and high solubility offered by drugs with nanoformed APIs is lowering the pill burden on patients and reducing side effects caused by high doses. Explore the evolving technologies enabling this shift toward improved quality of life and the potential of nanotechnology to aid this transition.